Shanghai MicroPort Endovascular MedTech Group Co Ltd
SSE:688016
Wall Street
Price Targets
Price Targets Summary
Shanghai MicroPort Endovascular MedTech Group Co Ltd
According to Wall Street analysts, the average 1-year price target for Shanghai MicroPort Endovascular MedTech Group Co Ltd is 241.77 CNY with a low forecast of 232.3 CNY and a high forecast of 264.74 CNY.
Price Targets
Revenue
Forecast
Revenue Estimate
Shanghai MicroPort Endovascular MedTech Group Co Ltd
For the last 6 years the compound annual growth rate for Shanghai MicroPort Endovascular MedTech Group Co Ltd's revenue is 39%. The projected CAGR for the next 3 years is 29%.
Operating Income
Forecast
Operating Income Estimate
Shanghai MicroPort Endovascular MedTech Group Co Ltd
For the last 6 years the compound annual growth rate for Shanghai MicroPort Endovascular MedTech Group Co Ltd's operating income is 40%. The projected CAGR for the next 3 years is 29%.
Net Income
Forecast
Net Income Estimate
Shanghai MicroPort Endovascular MedTech Group Co Ltd
For the last 6 years the compound annual growth rate for Shanghai MicroPort Endovascular MedTech Group Co Ltd's net income is 41%. The projected CAGR for the next 3 years is 30%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Shanghai MicroPort Endovascular MedTech Group Co Ltd's stock price target?
Price Target
241.77
CNY
According to Wall Street analysts, the average 1-year price target for Shanghai MicroPort Endovascular MedTech Group Co Ltd is 241.77 CNY with a low forecast of 232.3 CNY and a high forecast of 264.74 CNY.
What is Shanghai MicroPort Endovascular MedTech Group Co Ltd's Revenue forecast?
Projected CAGR
29%
For the last 6 years the compound annual growth rate for Shanghai MicroPort Endovascular MedTech Group Co Ltd's revenue is 39%. The projected CAGR for the next 3 years is 29%.
What is Shanghai MicroPort Endovascular MedTech Group Co Ltd's Operating Income forecast?
Projected CAGR
29%
For the last 6 years the compound annual growth rate for Shanghai MicroPort Endovascular MedTech Group Co Ltd's operating income is 40%. The projected CAGR for the next 3 years is 29%.
What is Shanghai MicroPort Endovascular MedTech Group Co Ltd's Net Income forecast?
Projected CAGR
30%
For the last 6 years the compound annual growth rate for Shanghai MicroPort Endovascular MedTech Group Co Ltd's net income is 41%. The projected CAGR for the next 3 years is 30%.